SCHEMBL24754530

SCHEMBL24754530

C=C/C=N\c1c(C)cccc1O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 3/20 0.43
TRPA1 O75762 2/20 0.43
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
HSP90AA1 P07900 1/20 0.41
ALDH1A1 P00352 6/20 0.40
MAPT P10636 5/20 0.40
KDM4E B2RXH2 4/20 0.40
POLB P06746 4/20 0.40
MPI P34949 2/20 0.40
L3MBTL1 Q9Y468 2/20 0.40
RECQL P46063 2/20 0.40
GAA P10253 4/20 0.34
HSD17B10 Q99714 3/20 0.34
HPGD P15428 3/20 0.34
ALOX12 P18054 2/20 0.34
LMNA P02545 2/20 0.34
ALOX15 P16050 2/20 0.34
DHODH Q02127 1/20 0.34
THRB P10828 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25847142 0.88 ATM (0.38) ATMTRPA1KMT2AMEN1HSP90AA1
SCHEMBL21130456 0.80 ATM (0.46) ATMTRPA1KMT2AMEN1HSP90AA1
SCHEMBL22245540 0.79 MEN1 (0.32) ATMKMT2AMEN1HSP90AA1
SCHEMBL20406187 0.79 CD44 (0.42) ATMKMT2AMEN1HSP90AA1ALDH1A1
SCHEMBL21651066 0.79 POLB (0.37) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL20725206 0.79
SCHEMBL20406636 0.78 GRIN2D (0.37) ATMKMT2AMEN1HSP90AA1ALDH1A1
SCHEMBL25801459 0.77 GABRA1 (0.35) ATMKMT2AMEN1HSP90AA1ALDH1A1
SCHEMBL13779331 0.74 MAPT (0.57) KMT2AMEN1ALDH1A1MAPTKDM4E
SCHEMBL4350537 0.74 ATM (0.43) ATMTRPA1KMT2AMEN1HSP90AA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220401432-A1 THERAPEUTIC METHODS, COMBINATIONS AND KITS REGENTS OF THE UNIVERSITY OF MINNESOTA 2022-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220401432-A1 THERAPEUTIC METHODS, COMBINATIONS AND KITS MMP8, TLR7, GOT2 ATM 3968/4885TRPA1 4779/4885KMT2A 2517/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.